- Home
- SXTP vs AKAN Comparison
SXTP vs AKAN Comparison
Compare SXTP & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- AKAN
- Stock Information
- Founded
- SXTP 2010
- AKAN 2021
- Country
- SXTP United States
- AKAN Canada
- Employees
- SXTP N/A
- AKAN N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- AKAN Medicinal Chemicals and Botanical Products
- Sector
- SXTP Health Care
- AKAN Health Care
- Exchange
- SXTP Nasdaq
- AKAN Nasdaq
- Market Cap
- SXTP 3.4M
- AKAN 2.9M
- IPO Year
- SXTP 2023
- AKAN 2022
- Fundamental
- Price
- SXTP $1.39
- AKAN $3.43
- Analyst Decision
- SXTP Buy
- AKAN
- Analyst Count
- SXTP 2
- AKAN 0
- Target Price
- SXTP $3.00
- AKAN N/A
- AVG Volume (30 Days)
- SXTP 77.5K
- AKAN 158.7K
- Earning Date
- SXTP 08-13-2025
- AKAN 10-29-2025
- Dividend Yield
- SXTP N/A
- AKAN N/A
- EPS Growth
- SXTP N/A
- AKAN N/A
- EPS
- SXTP N/A
- AKAN N/A
- Revenue
- SXTP $984,494.00
- AKAN $836,664.00
- Revenue This Year
- SXTP $81.41
- AKAN N/A
- Revenue Next Year
- SXTP $95.63
- AKAN N/A
- P/E Ratio
- SXTP N/A
- AKAN N/A
- Revenue Growth
- SXTP 128.70
- AKAN 97.47
- 52 Week Low
- SXTP $1.22
- AKAN $2.91
- 52 Week High
- SXTP $12.45
- AKAN $8.75
- Technical
- Relative Strength Index (RSI)
- SXTP 46.47
- AKAN 42.73
- Support Level
- SXTP $1.33
- AKAN $3.14
- Resistance Level
- SXTP $1.45
- AKAN $3.86
- Average True Range (ATR)
- SXTP 0.08
- AKAN 0.39
- MACD
- SXTP 0.02
- AKAN -0.05
- Stochastic Oscillator
- SXTP 54.20
- AKAN 23.20
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.